BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Strides Pharma Science Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
532531
ISIN Demat
INE939A01011
Book Value (Rs)
346.3871872
NSE Symbol
STAR
Divident Yield %
0.43
Market Cap
(Rs In Cr.)
8,624
P/E (TTM)
139.85
EPS (TTM)
6.69
Face Value
(Rs)
10
Back
Strides Pharma Science consolidated net profit rises 77.52% in the September 2025 quarter
31-Oct-25   Hrs IST

Net profit of Strides Pharma Science rose 77.52% to Rs 127.53 crore in the quarter ended September 2025 as against Rs 71.84 crore during the previous quarter ended September 2024. Sales rose 4.62% to Rs 1220.83 crore in the quarter ended September 2025 as against Rs 1166.93 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales1220.831166.93 5
OPM %18.8815.76 -
PBDT211.53138.53 53
PBT161.8990.08 80
NP127.5371.84 78

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)